Pharmacy

More Articles ...

More Articles ...

The FINANCIAL -- Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which ...

The FINANCIAL -- Bayer AG has reduced its direct interest in Covestro from 24.6 percent to 14.2 percent, selling a total of 21 million shares at a price of EUR 86.25 per ...

The FINANCIAL -- Novartis on January 17 announced that its supplemental Biologics License Application (sBLA) for KymriahTM (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, for ...

The FINANCIAL -- Takeda Pharmaceutical Company Limited on January 22 announced that the European Commission (EC) extended the current conditional marketing authorization of ADCETRIS (brentuximab ...

Videos

Watch the video